BullseyeAlertsBullseyeAlerts Facebook ad: “This Tiny Biotech Already Has FDA Revenue”
Ran for 15 days, from May 22 to June 5, 2026, the last day Crush saw it.
Run by BullseyeAlerts on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Want an ad like this for your product?
Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.
Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.
About this ad
- Meta Ad Library ID
- 1227189136022682
- Platforms
- Facebook and Instagram
- Relaunches
- 0
Ad text
🚨 Most biotech penny stocks have no approved drugs and no revenue. This one already launched an FDA approved cancer treatment and generated $5.6 million in just four months. Now Wall Street is watching two additional late-stage drugs targeting billion-dollar markets. Most investors have never heard of it. Tap below to get the full report free.
Where the ad sends people
fb.me
This Tiny Biotech Already Has FDA Revenue
Free research report + daily stock alerts.
Sign up: fb.me(opens in a new tab)
